Pre-Pectoral Breast Reconstruction after Mastectomy: Current Evidence, Knowledge Gaps, and Rationale for the I-PREPARE EUBREAST-11R Trial.
Rosa Di Micco, Lorenzo Scardina, Edoardo Botteri...
https://pubmed.ncbi.nlm.nih.gov/42383235/Actively Recruiting
Led by European Breast Cancer Research Association of Surgical Trialists · Updated on 2026-09-11
1236
Participants Needed
11
Research Sites
25 weeks
Total Duration
Researchers are conducting an international multicenter prospective cohort study to collect data on breast reconstruction techniques using pre-pectoral implants after mastectomy for breast cancer. The study aims to gather information on surgical, aesthetic, and cancer-related outcomes, as well as patient quality of life following this specific type of breast reconstruction. The study involves 1,236 female patients who undergo mastectomy and subsequent pre-pectoral implant-based breast reconstruction using an implant or expander, with or without mesh. Being an observational study, patients diagnostic and treatment plans will not be altered, and no additional risks are expected. The study will evaluate outcomes such as implant loss, infections, re-admissions, re-operations, and complications at several time points postoperatively. Participants will be monitored up to 24 months after surgery to assess quality of life and track early and late complications related to the reconstruction. Data collection will occur at intervals including three months, six months, 12 months, and 24 months post-surgery. This study helps provide future patients and surgeons with valuable information to guide decisions about breast reconstruction using the pre-pectoral approach.
CONDITIONS
International Prospective REgistry on Pre-pectorAl Breast REconstruction
O
Oreste D Gentilini, Dr
R
Rosa Di Micco, Dr
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
European Breast Cancer Research Association of Surgical Trialists
Lead Sponsor
EUBREAST ETS
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote) for screening and consent
Duration - Single surgical event
Participants undergo their planned mastectomy and pre-pectoral breast reconstruction without changes from the study.
Surgery day and immediate post-operative care visits
Duration - 24 months
Researchers collect data on implant loss, infections, complications, re-admissions, and quality of life over 24 months after surgery.
Assessments at 0, 3, 6, 12, and 24 months post-surgery
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Rosa Di Micco, Lorenzo Scardina, Edoardo Botteri...
https://pubmed.ncbi.nlm.nih.gov/42383235/European Breast Cancer Research Association of Surgical Trialists
Lead Sponsor
EUBREAST ETS
Collaborating Sponsor